AOD 9604 5mg peptide (Advanced Obesity Drug fragment 176-191). Stimulates lipolytic pathways without affecting glycemic markers.
Modified fragment of growth hormone C-terminal region engineered to stimulate lipolysis and inhibit lipogenesis without insulin resistance induction.
All Bachem AG compounds are stored in temperature-regulated clean-room facilities prior to packaging. Always verify batch coding and store out of direct sunlight.
| Quantity | 5 mg vial |
| Compound | AOD 9604 Peptide Fragment |
| Quality | Certified by Bachem AG |